B-Cell Non-Hodgkin Lymphoma Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working

Non-lymphoma Hodgkin's is cancer that starts in the lymphatic system, which is part of the body's immune system. White blood cells called lymphocytes proliferate improperly in non-lymphoma Hodgkin's and can form tumors throughout the body.

Non-lymphoma Hodgkin's is a type of lymphoma that is not Hodgkin's lymphoma. This category encompasses a wide range of subcategories. The most prevalent subtypes are diffuse large B-cell lymphoma and follicular lymphoma. Hodgkin's lymphoma is the other major type of lymphoma. 

DelveInsight’s “B-Cell Non-Hodgkin Lymphoma – Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the B-Cell Non-Hodgkin Lymphoma, historical and forecasted epidemiology as well as the B-Cell Non-Hodgkin Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 Some of the key facts of the B-Cell Non-Hodgkin Lymphoma Market Report: 

  • Non-lymphoma Hodgkin's can strike at any age, but it is more common as people get older. It is more common in adults aged 60 and above

  • In India, B-cell NHL accounts for 80-85% of all NHLs [10, 1314]. The most common subtype of NHL is diffuse large B-cell NHL (60 percent), followed by indolent lymphoma (12-20 percent). T-cell lymphomas make for 10-15% of all cases.

  • Non-Hodgins' lymphoma (NHL) is the most prevalent hematological disease, accounting for roughly 3% of all cancer diagnoses and deaths worldwide.

  • NHL accounts for almost 4% of cancer diagnoses in the United States, with a 168 percent rise in incidence since 1975.

To request a sample of the report: https://www.delveinsight.com/sample-request/b-cell-non-hodgkin-lymphoma-marke

B-Cell Non-Hodgkin Lymphoma Symptoms:

Symptoms of the Non-Hodgkin Lymphoma are-

  • Swollen Lymph nodes can be seen in the Neck, Groin, and armpits area

  • Pain or Swelling in the Abdominal Area

  • Body Fatigue

  • Abrupt Weight loss

  • Sweating in the night 

B-Cell Non-Hodgkin Lymphoma Market 

The dynamics of the B-Cell Non-Hodgkin Lymphoma market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as and others during the forecasted period 2022-2032.

Due to the high prevalence of the Non-Hodgkin Lymphoma, the ongoing market trends are mainly focused on launches of advanced products. Some Key Players in the market are- Genmab

Hoffmann-La Roche, BioInvent International AB, CARsgen Therapeutics Co., Ltd.

 Learn more by requesting for sample @ B-Cell Non-Hodgkin Lymphoma Market Landscape  

B-Cell Non-Hodgkin Lymphoma Pipeline Therapies: 

  • GEN3009

  • Epcoritamab

  • Mosunetuzumab (IV)

  • Polatuzumab Vedotin

  • BI1206

  • Epcoritamab 

B-Cell Non-Hodgkin Lymphoma and Key Companies:

  • Genmab

  • Hoffmann-La Roche

  • BioInvent International AB

  • CARsgen Therapeutics Co., Ltd.

  • The First Affiliated Hospital of Soochow University

  • Peking University

  • Beijing Cancer Hospital

Click here to read more about B-Cell Non-Hodgkin Lymphoma Market Outlook 2032 

Related Reports:

 B-Cell Non-Hodgkin Lymphoma Pipeline  

"B-Cell Non-Hodgkin Lymphoma Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the B-Cell Non-Hodgkin Lymphoma market. A detailed picture of the B-Cell Non-Hodgkin Lymphoma pipeline landscape is provided, which includes the disease overview and B-Cell Non-Hodgkin Lymphoma treatment guidelines. 

B-Cell Non-Hodgkin Lymphoma Epidemiology 

DelveInsight's 'B-Cell Non-Hodgkin Lymphoma  Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted B-Cell Non-Hodgkin Lymphoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports by DelveInsight

Basal Cell Carcinoma Market

Birch Allergy Market

Bile Duct Neoplasm Market

Gingivitis Market

LAG 3: A Promising Next Generation Cancer Immunotherapy

Comments

Post a Comment

Popular posts from this blog

The Great PD-1 Inhibitor Battle: OPDIVO vs. KEYTRUDA in Japan

Image
  Analyzing OPDIVO’s Pre-2022 Sales Decline and KEYTRUDA’s Market Ascendancy Before 2022, OPDIVO, developed by Bristol-Myers Squibb (BMS), faced a significant sales decline in Japan’s PD-1 inhibitor market. Despite its initial success, the PD-1 and PD-L1 inhibitors faced challenges from new competitors and evolving market dynamics. One key competitor was Merck's KEYTRUDA, which steadily gained market share due to its broader range of approved indications and successful clinical trial outcomes. KEYTRUDA’s market ascendancy was marked by its approval for various cancers, including melanoma, non-small cell lung cancer, and urothelial carcinoma, among others, making it a versatile choice for oncologists. How OPDIVO Outpaced KEYTRUDA in Japan’s Pharmaceutical Market In 2022, OPDIVO made a remarkable comeback, outpacing KEYTRUDA in Japan’s pharmaceutical market. This resurgence was driven by several strategic moves by BMS. The company expanded OPDIVO’s indications, securing approvals fo
Read more

A detailed analysis of Vascular Stents Market Trends, Growth Opportunities, Challenges, and Epidemiology Forecast

Image
A vascular surgeon places a stent, which is a hollow mesh tube that supports the blood vessel's walls permanently and prevents it from closing up again (restenosis). Some stents are drug-eluting, which means they release medicine over time to help prevent another blockage. The  Vascular Stents market is being driven by a growing geriatric population as well as an increase in the number of surgical operations. The  Vascular Stents Market report from DelveInsight provides an in-depth analysis of  Vascular Stents, as well as historical and forecasted market trends in the 7MM (the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Some Key Highlights from the  Vascular Stents Market Report The artery is kept open by a stent, which is a small metal mesh tube. The two methods for opening clogged peripheral arteries are angioplasty and stent implantation. Vascular Stents market is segmented on the basis of Product type, By Applications and End-user. Some of the
Read more
Image
Obstructive Sleep Apnea Market Trends and Therapeutic Advancements !! Obstructive Sleep Apnea (OSA) is a common chronic sleep disorder, which is characterized by periodic narrowing and obstruction of the pharyngeal airway during sleep, leading to a complete or partial obstruction of the airway, results of which are apneas, hypopneas, or sometimes both. Obstructive sleep apnea is a chronic and permanent condition, through proper therapy and medications the condition can be cured. Almost every system in the body is affected by Obstructive Sleep Apnea, resulting in an increased incidence of hypertension, stroke, altered immune system, and cardiovascular disease.  Obstructive Sleep Apnea is caused when the throat muscles relax during sleep, which causes the tissue in the back of the throat to collapse and block the upper airway. Daytime sleepiness is one of the most common symptoms of Obstructive Sleep Apnea. People affected with Obstructive Apnea also complain of memory problems, headach
Read more